The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| OGI | -3.29% | -72.67% | -22.85% | -71% |
| S&P | +17.12% | +80.95% | +12.59% | +246% |
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
Organigram recently published its Q2 report, and the market isn't happy with the results.
Vapes and chocolate edibles are among the new cannabis products the company is rolling out to medical marijuana consumers.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $80.06M | 79.1% |
| Gross Profit | $416.00K | 116.4% |
| Gross Margin | 0.52% | 6.2% |
| Market Cap | $378.80M | 42.4% |
| Market Cap / Employee | $332.57K | 0.0% |
| Employees | 1.1K | 26.8% |
| Net Income | -$37,964.00K | -598.8% |
| EBITDA | -$23,087.00K | -49.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $83.59M | -37.0% |
| Accounts Receivable | $63.59M | 94.7% |
| Inventory | 124 | 50.2% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $7.75M | 130.0% |
| Short Term Debt | $1.00M | -7.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -5.10% | 7.8% |
| Return On Invested Capital | -31.96% | 4.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$554.00K | -106.8% |
| Operating Free Cash Flow | -$1,318.00K | -113.3% |
| Metric | Q1 2025 | Q2 2025 | YoY Change | ||
|---|---|---|---|---|---|
| Price to Earnings | 14.12 | 61.33 | - | ||
| Price to Book | 0.82 | 0.57 | 0.63 | 0.98 | 14.05% |
| Price to Sales | 1.57 | 1.01 | 1.10 | 1.46 | -12.30% |
| Price to Tangible Book Value | 0.84 | 0.77 | 0.86 | 1.34 | 51.06% |
| Price to Free Cash Flow TTM | 100.05 | - | |||
| Enterprise Value to EBITDA | -12.37 | -7.86 | -10.94 | -13.11 | 47.61% |
| Free Cash Flow Yield | 1.0% | - | |||
| Return on Equity | -18.1% | 5.1% | 2.3% | -7.6% | -51.96% |
| Total Debt | $9.94M | $9.54M | $9.15M | $8.75M | 96.45% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
